AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2018

Nov 17, 2018

30071_dirs_2018-11-16_82703373-f78e-44d3-9e50-7dcfe4befff7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-14

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-14	ResMed Common Stock	A	2533	—	Acquired	24284	Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2019, or the annual shareholder's meeting in the year following the grant date.